HS
CERE
HighVista Strategies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-97,200
| Closed | -$3.97M | – | 173 |
|
|
2024
Q2 | $3.97M | Hold |
97,200
| – | – | 1.45% | 13 |
|
|
2024
Q1 | $4.11M | Hold |
97,200
| – | – | 1.47% | 14 |
|
|
2023
Q4 | $4.12M | Buy |
97,200
+72,313
| +291% | +$3.07M | 1.5% | 12 |
|
|
2023
Q3 | $543K | Buy |
+24,887
| New | +$543K | 0.25% | 99 |
|
|
2022
Q4 | – | Sell |
-23,611
| Closed | -$667K | – | 130 |
|
|
2022
Q3 | $667K | Sell |
23,611
-4,839
| -17% | -$137K | 0.38% | 71 |
|
|
2022
Q2 | $752K | Buy |
+28,450
| New | +$752K | 0.45% | 49 |
|